FDA Adverse Event Injury Summary report: N

LAMITRODE S-SERIES SURGICAL LEAD

MDR report key: 1870562 · Received September 29, 2010

Report

Report Number
1627487-2010-02189
Event Type
Injury
Date Received
September 29, 2010
Date of Event
June 24, 2009
Report Date
June 24, 2009
Manufacturer
ADVANCED NEUROMODULATION SYSTEMS
Product Code
LGW
PMA / PMN Number
P010032
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NL
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

THIS MDR IS BEING SUBMITTED PAST THE 30 DAY REPORTING REQUIREMENT AS PART OF A RETROSPECTIVE REVIEW INITIATED IN RESPONSE TO AN FDA INSPECTION. A RETROSPECTIVE REVIEW OF THE COMPLAINT RECORD DETERMINED THAT ANS MISINTERPRETED THE MDR REGULATIONS IN THIS INSTANCE. ANS HAS LIMITED INFORMATION RELATED TO THE PATIENT'S MEDICAL HISTORY AND IS UNABLE TO FORM AN OPINION AS TO THE RELEVANCY OF THE PATIENT'S HISTORY TO THE EVENT REPORTED. ANS DEFERS TO THE PATIENT'S PHYSICIAN REGARDING MEDICAL HISTORY.

Description of Event or Problem · 1

DEVICE 2 OF 2. REFERENCE: MANUFACTURER REPORT 1627487-2010-02188. THE PATIENT ((B)(6)) RECEIVED HIS SCS SYSTEM, WHICH INCLUDED ONE SURGICAL LEAD, ONE LEAD EXTENSION AND AN IPG, ON (B)(6) 2009. THE MODEL NUMBER OF THE SURGICAL LEAD WAS NOT PROVIDED AT THE TIME OF THE REPORT. IT WAS REPORTED THE PATIENT INVOLVED IN AN ACCIDENT WHICH LEAD TO A FALL. THE PATIENT REPORTED THAT AFTER THE ACCIDENT, HE COULD NO LONGER FEEL STIMULATION FROM HIS IPG. EXAMINATION OF THE PATIENT FOUND HIS LEAD HAD MIGRATED FROM T7 TO T4. DURING THE REVISION PROCEDURE ON (B)(6) 2009, IPG HAD INVALID AND UNSTABLE IMPEDANCES. THE IPG WAS EXPLANTED AND REPLACED AND THE LEAD WAS SUCCESSFULLY REPOSITIONED. THE EXPLANTED IPG WAS RETURNED TO THE MANUFACTURER FOR ANALYSIS. NO ADDITIONAL INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 LAMITRODE S-SERIES SURGICAL LEAD SPINAL CORD STIMULATION LEAD LGW ADVANCED NEUROMODULATION SYSTEMS

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention